Gene-Eluting Stents: Comparison of Adenoviral and Adeno- Associated Viral Gene Delivery to the Blood Vessel Wall In Vivo
- 1 July 2006
- journal article
- research article
- Published by SAGE Publications in Human Gene Therapy
- Vol. 17 (7) , 741-750
Abstract
Gene-eluting stents are being evaluated in animals as an alternative approach to inhibiting in-stent restenosis. Adeno-associated virus type 2 (AAV2) and adenovirus are commonly used for gene transfer applications. We tested the hypothesis that these vectors can achieve prolonged and localized gene delivery to the vessel wall, using stents as delivery platforms. AdβGal (5 × 109 plaque-forming units) and AAV2βGal (5.3 × 109 DNase-resistant particles) were used to coat BiodivYsio stents with matrix HI coating (Abbott Vascular Devices, Galway, Ireland). After balloon injury, external iliac arteries of New Zealand White rabbits were stented. The reverse transcription-polymerase chain reaction was used to assess viral spread. Expression of LacZ was demonstrated with both vectors at five time points (3, 7, 14, 21, and 28 days). In the adenovirus group the median percentage of cells expressing the transgene on day 3 was 2.73%, which increased to a median expression of 7.31% at 28 days (p > 0.05). Expression was localized to medial cells on day 3, but was observed predominantly in neointimal cells on day 28. In the AAV group, day 3 expression was 5.78%, which decreased to 2.12% on day 28 (p = 0.05). No systemic dissemination of virus was seen in any group. Adenovirus- and AAV2-coated stents can be used to deliver genes to the blood vessel wall for up to 28 days.Keywords
This publication has 21 references indexed in Scilit:
- Purification of adenovirus and adeno-associated virus: comparison of novel membrane-based technology to conventional techniquesGene Therapy, 2005
- Stent-Based Delivery of Tissue Inhibitor of Metalloproteinase-3 Adenovirus Inhibits Neointimal Formation in Porcine Coronary ArteriesArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Efficient Transduction of Vascular Endothelial Cells with Recombinant Adeno-Associated Virus Serotype 1 and 5 VectorsHuman Gene Therapy, 2005
- Gene transfer into rabbit arteries with adeno‐associated virus and adenovirus vectorsThe Journal of Gene Medicine, 2004
- LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1Science, 2003
- Inhibition of Retinal Neovascularization by Intraocular Viral-Mediated Delivery of Anti-angiogenic AgentsMolecular Therapy, 2002
- Gene delivery from a DNA controlled-release stent in porcine coronary arteriesNature Biotechnology, 2000
- Highly Purified Recombinant Adeno-Associated Virus Vectors Are Biologically Active and Free of Detectable Helper and Wild-Type VirusesHuman Gene Therapy, 1999
- Patterns and Mechanisms of In-Stent RestenosisCirculation, 1996
- Cell Lines for the Production of Recombinant Adeno-Associated VirusHuman Gene Therapy, 1995